Elite Pharmaceuticals (ELTP) Short Interest Ratio & Short Volume → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free ELTP Stock Alerts $0.13 +0.00 (+2.32%) (As of 04/26/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Elite Pharmaceuticals Short Interest DataCurrent Short Volume1,601,300 sharesPrevious Short Volume1,555,700 sharesChange Vs. Previous Month+2.93%Dollar Volume Sold Short$216,175.50Short Interest Ratio / Days to Cover1.4Last Record DateApril 15, 2024Outstanding Shares1,068,270,000 sharesPercentage of Shares Shorted0.15%Today's Trading Volume290,000 sharesAverage Trading Volume1,205,179 sharesToday's Volume Vs. Average24% Short Selling Elite Pharmaceuticals ? Sign up to receive the latest short interest report for Elite Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatELTP Short Interest Over TimeELTP Days to Cover Over TimeELTP Percentage of Float Shorted Over Time Ad Prosper Trading AcademyThis AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free Copy Elite Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,601,300 shares $216,175.50 +2.9%N/A1.4 $0.14 3/31/20241,555,700 shares $240,106.74 -7.7%N/A1.4 $0.15 3/15/20241,684,700 shares $234,173.30 +5.1%N/A0.9 $0.14 2/29/20241,602,900 shares $258,066.90 +0.9%N/A0.4 $0.16 2/15/20241,588,800 shares $293,769.12 +75.2%N/A0.5 $0.18 1/15/2024103,200 shares $18,008.40 +24.8%N/A0 $0.17 Get the Latest News and Ratings for ELTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/202382,700 shares $11,578.00 No ChangeN/A0 $0.14 11/30/202380,600 shares $11,084.11 +58.4%N/A0 $0.14 11/15/202350,900 shares $7,380.50 No ChangeN/A0 $0.15 10/15/2023228,000 shares $21,831.00 +113.5%N/A0.3 $0.10 9/30/2023106,800 shares $10,019.44 +862.2%N/A0.1 $0.09 9/15/202311,100 shares $865.80 -94.8%N/A0 $0.08 8/31/2023211,700 shares $18,629.60 +1,283.7%N/A0 $0.09 8/15/202315,300 shares $711.45 -74.6%N/A0 $0.05 7/31/202360,300 shares $2,532.60 +102.4%N/A0 $0.04 7/15/202329,800 shares $1,132.40 No ChangeN/A0 $0.04 6/15/202311,000 shares $374.00 -7.6%N/A0 $0.03 5/31/202311,900 shares $367.71 +643.8%N/A0 $0.03 5/15/20231,600 shares $49.44 -85.7%N/A0 $0.03 4/30/202311,200 shares $369.60 +3,633.3%N/A0 $0.03 4/15/2023300 shares $9.30 -93.6%N/A0 $0.03 3/31/20234,700 shares $136.30 +193.8%N/A0 $0.03 3/15/20231,600 shares $50.40 -20.0%N/A0 $0.03 2/28/20232,000 shares $71.20 -95.5%N/A0 $0.04 2/15/202344,200 shares $1,701.70 +44.9%N/A0.1 $0.04 1/31/202330,500 shares $1,030.90 +74.3%N/A0 $0.03 1/15/202317,500 shares $525.00 +2,087.5%N/A0 $0.03 12/30/2022800 shares $23.60 +700.0%N/A0 $0.03 12/15/2022100 shares $3.00 -99.0%N/A0 $0.03 11/30/202210,000 shares $329.00 -54.3%N/A0 $0.03 11/15/202221,900 shares $755.55 +1,268.8%N/A0.1 $0.03 10/31/20221,600 shares $57.28 -96.3%N/A0 $0.04 10/15/202242,800 shares $1,326.80 No ChangeN/A0 $0.03 9/15/2022400 shares $14.40 -99.4%N/A0 $0.04 8/31/202269,300 shares $2,477.48 -2.8%N/A0 $0.04 8/15/202271,300 shares $3,208.50 No ChangeN/A0.1 $0.05 7/15/20221,000 shares $42.90 -83.1%N/A0 $0.04 6/30/20225,900 shares $295.00 No ChangeN/A0 $0.05 5/31/20222,700 shares $123.39 No ChangeN/A0 $0.05 4/15/202216,900 shares $611.44 No ChangeN/A0 $0.04Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ELTP Short Interest - Frequently Asked Questions What is Elite Pharmaceuticals' current short interest? Short interest is the volume of Elite Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 1,601,300 shares of ELTP short. Learn More on Elite Pharmaceuticals' current short interest. What is a good short interest ratio for Elite Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELTP shares currently have a short interest ratio of 1.0. Learn More on Elite Pharmaceuticals's short interest ratio. Is Elite Pharmaceuticals' short interest increasing or decreasing? Elite Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,601,300 shares, an increase of 2.9% from the previous total of 1,555,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Elite Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Elite Pharmaceuticals: Annovis Bio, Inc. (13.17%), Amylyx Pharmaceuticals, Inc. (13.87%), Vistagen Therapeutics, Inc. (5.31%), Zomedica Corp. (6.30%), Sagimet Biosciences Inc. (12.02%), Syros Pharmaceuticals, Inc. (10.10%), Karyopharm Therapeutics Inc. (20.23%), Repare Therapeutics Inc. (2.13%), Citius Pharmaceuticals, Inc. (8.29%), Biophytis S.A. (2.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Elite Pharmaceuticals stock? Short selling ELTP is an investing strategy that aims to generate trading profit from Elite Pharmaceuticals as its price is falling. ELTP shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elite Pharmaceuticals? A short squeeze for Elite Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELTP, which in turn drives the price of the stock up even further. How often is Elite Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELTP, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Annovis Bio Short Interest Amylyx Pharmaceuticals Short Interest Vistagen Therapeutics Short Interest Zomedica Short Interest Sagimet Biosciences Short Interest Syros Pharmaceuticals Short Interest Karyopharm Therapeutics Short Interest Repare Therapeutics Short Interest Citius Pharmaceuticals Short Interest Biophytis Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ELTP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressGreat Crypto BullWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry